Nebenwirkungen · Rivastigmine 1 A Pharma
Rivastigmine 1 A Pharma 2 mg/ml oral solution · Abschnitt 4.8 · PDF-Seite 22
HOS-212460 · Präparat HOS-154894
Vascular disorders Very rare Hypertension Gastrointestinal disorders Very common Nausea Very common Vomiting Very common Diarrhoea Common Abdominal pain and dyspepsia Rare Gastric and duodenal ulcers Very rare Gastrointestinal haemorrhage Very rare Pancreatitis Not known Some cases of severe vomiting were associated with oesophageal rupture (see section 4.4). Hepatobiliary disorders Uncommon Elevated liver function tests Not known Hepatitis Skin and subcutaneous tissue disorders Common Hyperhydrosis Rare Rash Not known Pruritus, allergic dermatitis (disseminated)
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-20T13:50:00Z · SHA-256 131a9504ea601ff9f929650be1df38b3f3e958ac8aed8146800bb83c92474fa3 · Passage 1f22782e02c662c959aa95a897721955553af20b5c7d561c088113d2e4ae8abf · Zeichen 2744–3939 im Abschnitt